Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
23847studies shown
Showing 21,121-21,132 of 23,847
Drug study icon
CompletedNCT06572449

Effectiveness of Slowly Increasing Dose and Food Effect of KarXT in schizophrenia

This study is completed in the United States. It is testing Slowly Increasing Dose and Food Effect of KarXT for schizophrenia.

Multiple locations, including Los Alamitos
SchizophreniaDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
United States
Sponsor
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Condition
Schizophrenia
Drug study icon
CompletedNCT00228540

Satisfaction With Modafinil Treatment for ADHD

This study is completed in the United States. It is testing satisfaction With Modafinil Treatment for ADHD.

Multiple locations, including Scottsdale
ADHDDrugFrom 6 Years to 17 Years
Countries
United States
Sponsor
Cephalon
Condition
ADHD
Drug study icon
CompletedNCT06058039

Effects of Oral NMRA-335140 in people with Major Depressive Disorder

This study is completed in the United States, in France, in Bulgaria, .... It is testing Effects of Oral NMRA-335140 for depression.

Multiple locations, including Cerritos
DepressionDrugFrom 18 Years to 65 Years
Countries
United States, France, Bulgaria, ...
Sponsor
Neumora Therapeutics, Inc.
Condition
Depression
Drug study icon
CompletedNCT05203341

NBI-1065845 for depression

This study is completed in the United States, in Bulgaria, in Czechia, .... It is testing NBI-1065845 for depression.

Multiple locations, including Birmingham
DepressionDrugFrom 18 Years to 65 Years
Countries
United States, Bulgaria, Czechia, ...
Sponsor
Neurocrine Biosciences
Condition
Depression
Drug study icon
Active Not RecruitingNCT06029439

Safety and Effectiveness of NMRA-335140-501

This study is active but not recruiting in the United States, in France, in Canada, .... It focuses on Depression.

Multiple locations, including Huntsville
DepressionDrugFrom 18 Years to 65 Years
Countries
United States, France, Canada, ...
Sponsor
Neumora Therapeutics, Inc.
Condition
Depression
Drug study icon
CompletedNCT00334880

Safety study of Safety and Efficacy of NRP104 in ADHD

This study is completed in the United States. It is testing Safety and Efficacy of NRP104 for ADHD.

Multiple locations, including Little Rock
ADHDDrugFrom 18 Years to 55 Years
Countries
United States
Sponsor
New River Pharmaceuticals
Condition
ADHD
Drug study icon
CompletedNCT02411695

Safety study of Brexpiprazole (OPC- 34712) in schizophrenia

This study is completed in the United States. It is testing Brexpiprazole (OPC- 34712) for schizophrenia.

Multiple locations, including Little Rock
SchizophreniaDrugFrom 13 Years to 17 Years
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.